Clone of human fatty acid synthase promoter and analysis of its transcriptional activity in tumor cells

CHEN Yan,JIA Jun,QIN Hong-yan,HAN Hua
DOI: https://doi.org/10.3969/j.issn.1672-4992.2006.12.003
2006-01-01
Journal of Modern Oncology
Abstract:Objective:To clone the human fatty acid synthase gene promoter, construct the recombinant luciferase reporter plasmid pGL3-FAS and detect its transcriptional activities in several tumor cell lines and in NIH3T3 fibroblast cells in order to provide theoretical evidence for its use as tool for tumor targeted gene therapy. Methods: The fragment of FAS promoter was acquired by PCR amplification from human genome DNA and cloned into the luciferase reporter plasmid pGL3-enhance to construct pGL3-FAS. pGL3-FAS was transient transfected into human gastric carcinoma cell lines SGC-7901,human cervical carcinoma cell lines Hela,human breast cancer cell lines SKBR3,human hepatic cancer cell lines HepG2 and NIH3T3 fibroblast cells lines. The transcriptional activities of FAS promoter in these cells were detected by Luciferase Reporter Assay System. Results: The 680 bp hFAS promoter was successfully amplified by PCR and the sequence was accordance to the one published on Genebank. We successfully constructed the pGL3-FAS recombinant luciferase reporter vector. The hFAS promoter showed high transcriptional activities in all tumor cell lines but little in NIH3T3 fibroblast cells. The transcriptional activities of FAS promoter in tumor cells were significantly stronger than SV40 strong promoter. Conclusion: FAS promoter possesses the tumor-specific high transcriptional activity in tumor cell lines. It may serve as a useful tool for tumor targeted gene therapy.
What problem does this paper attempt to address?